New England Journal of Medicine· 2012Q1· Clinical trial
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
- 2,805citations
- Q1SCImago
- 2012year
Short summary
In patients with cardiogenic shock complicating acute myocardial infarction, intraaortic balloon counterpulsation (IABP) did not significantly reduce 30-day mortality compared to standard care when an early revascularization strategy was planned.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Biomedical Engineering
Biomedical EngineeringEngineering